Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > AbbVie buys IMGN
View:
Comment by 99942Apophis on Dec 03, 2023 10:14am
Good choice enriquesuave,  would've loved to see a more indepth calculation on EPS and ratio. One thing stands out here is the need for large pharmaceutical companies to grow through buyout. I wonder how long after BTD & AA do buyout offers start or will Theralase attempt to grow by use of Joint Ventures? 
Comment by Alamir1111 on Dec 03, 2023 11:21am
Imune has a treatment approved  and making 100s mil  a year.sorry can't compare us to them.
Comment by Alamir1111 on Dec 03, 2023 11:26am
And selling a sales pitch on keeping the lights on and small pp  man that is shark food
Comment by skys1 on Dec 03, 2023 11:34am
WOW!!! Alamir has 12 posts in the last 23 hours. Sure must have some type of agenda.
Comment by Alamir1111 on Dec 03, 2023 11:38am
So you reading it must be a fan?
Comment by Oilminerdeluxe on Dec 03, 2023 11:49am
That keep the lights on remark from Roger is perhaps not the best choice of words but in the context it was made it is nothing to pay attention to. It is a common saying after all. Anyway, perhaps nothing much will happen from now until they make that pre-BTD application.. Should be in January, so only a month a way. A loooong month. 
Comment by Benedictus on Dec 03, 2023 11:26pm
Yes, keeping the lights on is a common saying but there is an implied resignation in it imo. Staying on this shoestring budget and needing to outstretch the begging bowl again almost every single quarter must be a tiresome time-consuming ordeal. And let's not forget the poor optics of such a strategy. The goal was a fully funded $5.3M LIFE offering, giving them a full year of cash along with ...more  
Comment by enriquesuave on Dec 03, 2023 11:38pm
Right after this Roger stated they were looking at non dilutive financing in early 24 such as regional licensing or other deal.  Hopefully things move fast!
Comment by Alamir1111 on Dec 03, 2023 11:46pm
He stated a lot of things which never materilazed.Ask your al to characterize this behavior  you might get a proper ansver
Comment by Alamir1111 on Dec 03, 2023 11:41pm
Good post Benedictus  need more of you
Comment by O12009 on Dec 03, 2023 11:51am
And that is the reason for the ignore feature
Comment by Alamir1111 on Dec 03, 2023 11:56am
Good option you been terminated 
Comment by stocksnbonds458 on Dec 03, 2023 1:01pm
That sure would be wonderful!! If, by the time we are bought out, we are at 500M shares fully diluted, at 10 billion that would work out to $20 per share.
Comment by Alamir1111 on Dec 03, 2023 6:11pm
Did you see all the lawfirms going after imgn reason not happy with sale price.Do you think tlt shareholders would oppose such a deal?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250